⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVTX News
Avalo Therapeutics, Inc. Common Stock
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AVTX
Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates
globenewswire.com
AVTX
Avalo Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
AVTX
Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
globenewswire.com
AVTX
Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources
globenewswire.com
AVTX